Bio-Rad Reports Second-Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Needham Starts NeoVolta (NEOV) at Buy
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Hertz cuts guidance, announces notes and stock offerings, shares sink
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- SanDisk stock target lifted by Citi on continued demand strength
Bio-Rad Labs (BIO) Tops Q2 EPS by 37c
August 7, 2018 4:51 PM EDTBio-Rad Labs (NYSE: BIO) reported Q2 EPS of $1.64, $0.37 better than the analyst estimate of $1.27. Revenue for the quarter came in at $575.9 million versus the consensus estimate of $548.43 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
... More